Artiva Biotherapeutics, Inc. ARTV Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s quick ratio?
- Artiva Biotherapeutics, Inc. (ARTV) reported quick ratio of 8.2× in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s quick ratio changed year-over-year?
- Artiva Biotherapeutics, Inc.'s quick ratio decreased by 41.4% year-over-year, from 13.9× to 8.2×.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s quick ratio?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s quick ratio has grown at a 14.8% compound annual growth rate (CAGR), from 6.5× to 8.6×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.